DogeOS Launches Testnet to Bring DeFi Apps to Dogecoin 
Lynas Shares Slide on A$968 Million Meteoric Resources Deal 
California AG Subpoenas OpenAI Over AI Cybersecurity Incidents 
Volvo Cars Drops Full-Year Outlook as China, US Sales Weaken 
Bank of America Sees EUR/USD at 1.15 by Year-End 
Flydubai FZ1073 Co-Pilot Accused of Terror Attack 
AAVE, PUMP, WLD and SKY Rally as Crypto Market Slips 
Malaysia Aviation Group to Buy Airbus SAE Unit 
Ripple Locks 700 Million XRP Back in Escrow After October Release 
Disney Plans TV Restructuring With Hundreds of Layoffs 
SoftBank Shares Fall After $10 Billion OpenAI Investment 
Zcash Awards $8 Million in Grants After Orchard Bug Crisis 
Circle Urges EU to Revise MiCA Stablecoin Rules 
Nike Stock Slides as Revenue Miss Clouds Turnaround 
WordPress Malware Uses Ethereum to Evade Removal 
Evernorth Set for Nasdaq Debut With 473 Million XRP Treasury 
Coinbase, Circle Stocks Slide as Bank Group Sues OCC Over Crypto Charters 
Add as a preferred source on Google
CAMBRIDGE, Mass., Feb. 28, 2017 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will present at the Cowen and Company 37th Annual Health Care Conference. The presentation is scheduled for Tuesday, March 7th at 10:40 a.m. ET.
The webcast of the presentation will be available live on the “Investors” section of the company’s website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event.
About Momenta
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.
To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.
Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.
Contact: Sarah Carmody Momenta Pharmaceuticals 1-617-395-5189 [email protected]
